NeurOp, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neuropinc.com
A Multiple Ascending Dose Study of Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
Phase 1
Completed
- Conditions
- Stroke, IschemicSubstance AbusePain, PostoperativeSubarachnoid Hemorrhage
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Neurop Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04007263
- Locations
- 🇺🇸
Pharmaron CPC, Baltimore, Maryland, United States
Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
- First Posted Date
- 2018-06-21
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Neurop Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03565861
- Locations
- 🇺🇸
Pharmaron CPC, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath